The in vitro action of interferon (IFN)-α andIFN-γ from six healthy donors and ten patients with multiplesclerosis (MS) on natural killer (INK) activity of peripheral bloodlymphocytes (PBL) was studied in an autologous system. The gene discussed is IFNA1; the disease is myeloid sarcoma.